BREAKING
Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 10 hours ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 10 hours ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 11 hours ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 11 hours ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 11 hours ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 11 hours ago Science Applications International (SAIC) Beats Q4 EPS Estimates 11 hours ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 11 hours ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 13 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 14 hours ago Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 10 hours ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 10 hours ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 11 hours ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 11 hours ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 11 hours ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 11 hours ago Science Applications International (SAIC) Beats Q4 EPS Estimates 11 hours ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 11 hours ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 13 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 14 hours ago
ADVERTISEMENT
Analysis

Knife River Corporation Q4 2025 Revenue Rises 15% With 2026 Guidance Outlook

February 17, 2026 2 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results

Knife River Corporation (NYSE: KNF) reported financial results for the fourth quarter and full year ended December 31, 2025.

Current Status Overview

Share Price Performance

Revenue Performance

Revenue for the last three months (Q4 2025) totaled $755.1 million, representing a 15% increase from $657.2 million in Q4 2024. For the last six months (Q3 and Q4 2025 combined), revenue reached $1,958.8 million, compared with $1,762.5 million in the comparable 2024 period, reflecting growth of approximately 11%. Over the last nine months (Q2 through Q4 2025), revenue totaled $2,792.6 million versus $2,569.5 million in the prior-year period, an increase of approximately 8.7% year over year.

Market Analysis

Knife River operates in the construction materials and infrastructure services industry, with vertically integrated operations spanning aggregates, ready-mix concrete, asphalt, and contracting services across multiple U.S. markets. Industry trends include elevated public infrastructure investment, backlog expansion, and pricing discipline in materials. Competitive dynamics remain regional, with national and local producers competing for public and private construction contracts.

Analyst Commentary

No analyst commentary reported.

Mergers & Acquisitions

Knife River completed five aggregates-focused acquisitions during 2025, contributing to revenue growth and expanded geographic reach. No additional acquisitions were announced in the fourth-quarter 2025 earnings release.

Outlook

For full-year 2026, Knife River provided revenue guidance of $3,300 million to $3,500 million and Adjusted EBITDA guidance of $520 million to $560 million. Aggregates volumes and pricing are expected to increase in the mid-single-digit range, ready-mix volumes are projected to increase in the mid-teens, and asphalt volumes are anticipated to grow in the mid-single digits. The company expects continued operational execution and capital deployment aligned with infrastructure demand trends.

ADVERTISEMENT
Tags: #KNF